Evaluation of Two Silicone Hydrogel Lenses Over a One Month Period
NCT ID: NCT00810511
Last Updated: 2023-12-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
213 participants
INTERVENTIONAL
2008-11-30
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lotrafilcon A
Investigational, spherical, silicone hydrogel contact lenses
Lotrafilcon A contact lens
Silicone hydrogel contact lens
Comfilcon A
Commercially marketed, spherical, silicone hydrogel contact lenses
Comfilcon A contact lens
Silicone hydrogel contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon A contact lens
Silicone hydrogel contact lens
Comfilcon A contact lens
Silicone hydrogel contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a need for correction in both eyes and be correctable to at least 20/40 distance vision in each eye while wearing trial lenses
* Replace lenses on a weekly or longer schedule
Exclusion Criteria
* Eye injury or surgery within twelve weeks immediately prior to enrollment
* Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of their accessory solutions
* Current soft toric lens wearers
* Those who dispose of their soft lenses on a daily basis
* Current NIGHT \& DAY® or Biofinity® lens wearers
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CIBA VISION
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-335-C-007
Identifier Type: -
Identifier Source: org_study_id